Squamous Cell Carcinoma
Melanoma testing: Progress in practice
Anal cancer incidence, mortality rise sharply in US
Tipifarnib induces responses in HRAS-mutant head and neck squamous cell carcinoma
Top five articles not to miss from ASDS annual meeting
Expert: Dermatologists should take lead on cutaneous SCC

CHICAGO — In an educational session here at the American Society for Dermatologic Surgery annual meeting, Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, provided an update on squamous cell carcinoma, including how to prevent patients from entering the high-risk category and available treatment options.
World-renowned chef, cancer survivor encourages dermatologists to push the envelope
Severe psoriasis increases risk for cancer-related mortality
An increase in overall cancer mortality risk was found in patients with severe psoriasis, and associations were identified within site-specific cancers such as colon and kidney among patients with all severities of psoriasis, according to a systematic review of 58 studies that was published in JAMA Dermatology.
Single-agent, targeted therapies induce negligible response among smokers with NSCLC
BARCELONA — Targeted therapies for non-small cell lung cancer demonstrated potential benefit in additional molecular stratifications of the disease, according to results from the National Lung Matrix Trial presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.